Page last updated: 2024-08-24

tenofovir and Lymphopenia

tenofovir has been researched along with Lymphopenia in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anderson, PL; Becker, SL; Kakuda, TN	1
Barreiro, P; Barrios, A; Blanco, F; Clotet, B; Cooper, D; Domingo, P; Garcia-Benayas, T; Gil, P; Gonzalez-Lahoz, J; Labarga, P; Maida, I; Martín-Carbonero, L; Negredo, E; Núñez, M; Rendón, A; Sambeat, MA; Sánchez-Conde, M; Santos, J; Soriano, V	1
Girard, PM; Lacombe, K; Meynard, JL; Pacanowski, J; Trylesinski, A	1

Trials

1 trial(s) available for tenofovir and Lymphopenia

Article	Year
Paradoxical CD4+ T-cell decline in HIV-infected patients with complete virus suppression taking tenofovir and didanosine. AIDS (London, England), 2005, Mar-24, Volume: 19, Issue:6 Topics: Adenine; Adult; Anti-HIV Agents; CD4-Positive T-Lymphocytes; Didanosine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; HIV Infections; Humans; Lymphopenia; Male; Organophosphonates; Retrospective Studies; Tenofovir; Virus Replication	2005

Article

Year

Paradoxical CD4+ T-cell decline in HIV-infected patients with complete virus suppression taking tenofovir and didanosine.

AIDS (London, England), 2005, Mar-24, Volume: 19, Issue:6

Topics: Adenine; Adult; Anti-HIV Agents; CD4-Positive T-Lymphocytes; Didanosine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; HIV Infections; Humans; Lymphopenia; Male; Organophosphonates; Retrospective Studies; Tenofovir; Virus Replication

2005

Other Studies

2 other study(ies) available for tenofovir and Lymphopenia

Article	Year
CD4 cell decline with didanosine and tenofovir and failure of triple nucleoside/nucleotide regimens may be related. AIDS (London, England), 2004, Dec-03, Volume: 18, Issue:18 Topics: Adenine; Anti-HIV Agents; CD4-Positive T-Lymphocytes; Didanosine; Drug Interactions; Drug Therapy, Combination; HIV Infections; Humans; Lymphopenia; Organophosphonates; Purine-Nucleoside Phosphorylase; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Failure	2004
Risk factors for CD4 lymphopenia in patients treated with a tenofovir/didanosine high dose-containing highly active antiretroviral therapy regimen. AIDS (London, England), 2005, Jul-01, Volume: 19, Issue:10 Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Didanosine; Female; HIV Infections; Humans; Lymphopenia; Male; Organophosphonates; Risk Factors; Tenofovir	2005

Article

Year

CD4 cell decline with didanosine and tenofovir and failure of triple nucleoside/nucleotide regimens may be related.

AIDS (London, England), 2004, Dec-03, Volume: 18, Issue:18

Topics: Adenine; Anti-HIV Agents; CD4-Positive T-Lymphocytes; Didanosine; Drug Interactions; Drug Therapy, Combination; HIV Infections; Humans; Lymphopenia; Organophosphonates; Purine-Nucleoside Phosphorylase; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Failure

2004

Risk factors for CD4 lymphopenia in patients treated with a tenofovir/didanosine high dose-containing highly active antiretroviral therapy regimen.

AIDS (London, England), 2005, Jul-01, Volume: 19, Issue:10

Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Didanosine; Female; HIV Infections; Humans; Lymphopenia; Male; Organophosphonates; Risk Factors; Tenofovir

2005